Key Takeaways
- Electronic Lab Notebook (ELN) software adoption is accelerating as laboratories embrace cloud platforms, AI-powered workflows, digital collaboration, and paperless research environments.
- The ELN software market is positioned for sustained growth through 2030 and beyond, driven by pharmaceutical R&D, biotechnology, regulatory compliance, laboratory automation, and expanding cloud adoption.
- AI integration, LIMS-ELN convergence, measurable productivity gains, and rapid Asia-Pacific growth are among the most important Electronic Lab Notebook software trends shaping 2026.
Electronic Lab Notebook (ELN) software transforms how laboratories capture, manage, share, and protect research data. In 2026, growing cloud adoption, AI integration, regulatory requirements, and demand for efficient digital workflows are driving ELN adoption across pharmaceutical, biotechnology, academic, and industrial research environments worldwide.
Electronic Lab Notebook (ELN) software is becoming an increasingly important part of modern research infrastructure as laboratories move away from paper-based documentation toward connected, searchable, and auditable digital environments. From pharmaceutical and biotechnology companies to contract research organisations, universities, food laboratories, and industrial research facilities, ELN platforms are helping scientists manage growing volumes of experimental data while improving collaboration, compliance, reproducibility, and research productivity.
Also, read our article on the Top 10 Electronic Lab Notebook Software.

The Top 100 Electronic Lab Notebook (ELN) Software Statistics, Data & Trends in 2026 reveal a market undergoing sustained digital transformation. Industry forecasts in the dataset vary depending on market definitions, but several point toward continued expansion through the next decade. MarketsandMarkets projects the ELN market to reach $1.03 billion by 2030, while Toward Healthcare forecasts approximately $1.4 billion by 2034. Meanwhile, the cloud ELN segment is expanding particularly quickly, with the global laboratory cloud ELN market projected to grow at a 12.8% CAGR through 2033.
Adoption trends illustrate how ELNs are evolving beyond simple replacements for paper notebooks. According to the compiled statistics, approximately 64% of research facilities have adopted ELN platforms, while 67.92% of the market was represented by cloud-based deployment in 2024. Artificial intelligence is also becoming increasingly prominent: 58% of current ELN deployments incorporate AI or machine-learning features, and half of new ELN contracts signed in 2024 reportedly included AI-driven experiment-planning capabilities.
The business case for electronic lab notebooks is also increasingly tied to measurable productivity improvements. The statistics indicate that researchers can save an average of nine hours per week after implementing an ELN, while high-efficiency users may save as much as 17 hours per week. ELN users also report spending 33% less time on reporting, and measurable returns on investment may be achievable within three to four months of implementation. These gains help explain why ELNs are increasingly viewed as operational infrastructure rather than simply digital documentation tools.
Geographically, North America remains the largest ELN market, while Asia-Pacific is emerging as a major growth opportunity. The dataset places North America’s global market share at 37.65% in 2025, while Asia-Pacific is forecast to grow at an 8.71% CAGR between 2026 and 2031. Cloud adoption is moving even faster in the region, with the Asia-Pacific cloud ELN market projected to expand at a 15.1% CAGR through 2033.
At the same time, competition and technological convergence are reshaping the Electronic Lab Notebook software landscape. Cloud-native platforms, AI-assisted research, mobile data capture, LIMS integration, regulatory compliance, real-time collaboration, and unified laboratory informatics ecosystems are becoming increasingly important differentiators. Major industry developments, including Siemens’ $5.1 billion acquisition of Dotmatics in 2025, further demonstrate the strategic value being placed on digital research and life sciences software infrastructure.
This collection of 100 Electronic Lab Notebook software statistics for 2026 examines the numbers shaping the industry, including ELN market size and growth forecasts, cloud adoption, AI integration, regional market trends, pharmaceutical and biotechnology usage, researcher productivity, ROI, regulatory compliance, competitive dynamics, M&A activity, and emerging technology trends. Together, these data points provide a comprehensive view of where the ELN software market stands in 2026 and how digital laboratory technology could evolve over the years ahead.
Before we venture further into this article, we would like to share who we are and what we do.
About 9cv9
9cv9 is a business tech startup based in Singapore and Asia, with a strong presence all over the world.
With over ten years of startup and business experience, and being highly involved in connecting with thousands of companies and startups, the 9cv9 team has listed some of the top and best companies/tools in this review.
If you like to get your company listed in our top B2B software reviews, check out our world-class 9cv9 Media and PR service and pricing plans here.
Top 100 Electronic Lab Notebook (ELN) Software Statistics, Data & Trends in 2026
📈 SECTION 1: Market Size & Growth Projections (Stats #1–18)
#1. $700M → ~$720M (2024–2025)
The global Electronic Lab Notebook software market grew from approximately $700M in 2024 to an estimated $720M in 2025, reflecting consistent double-digit momentum as life sciences organisations accelerate laboratory digitalisation worldwide.
#2. $1.03 Billion by 2030
According to MarketsandMarkets, the ELN market is projected to reach $1.03 billion by 2030 at a CAGR of 7.3%, signalling that ELN software is transitioning from a niche research tool into core enterprise R&D infrastructure across pharma and biotech.
#3. $512.45M (Mordor Intelligence 2026 Estimate)
Mordor Intelligence estimates the ELN market at $512.45M in 2026, growing from $480.44M in 2025 — representing more than $30M in annual incremental growth — driven by cloud adoption and regulatory compliance requirements.
#4. $1.4 Billion by 2034
Toward Healthcare projects the global ELN market to reach $1.4 billion by 2034 at a 7.26% CAGR, with lab automation, AI integration, and strict data integrity regulations serving as the primary long-term growth catalysts.
#5. $595.58M (Verified Market Research, 2024)
Verified Market Research valued the ELN software market at $595.58M in 2024, projecting growth to $860M by 2032 at a 4.7% CAGR — demonstrating sustained, resilient expansion across pharmaceutical, academic, and industrial research sectors.
#6. $1.2B → $2.8B (Broad ELN Software Definition)
Using a broader software definition, Verified Market Reports estimated the ELN software market at $1.2B in 2024, forecasting growth to $2.8B by 2033 at a 10.5% CAGR — driven by cloud-native architecture and AI feature integration across lab workflows.
#7. 6.66% CAGR (2026–2031)
Mordor Intelligence forecasts the ELN market will grow at a 6.66% CAGR between 2026 and 2031, reaching $707M by 2031 — a steady expansion underpinned by regulatory compliance mandates and the global shift toward paperless laboratories.
#8. $613.5M (Market.US, 2023) → $1.276B by 2033
Market.US valued the global ELN market at $613.5M in 2023 and forecasts growth to $1.276B by 2033 at a 7.6% CAGR — representing a near-doubling of market size that underscores the sector’s strong structural growth tailwinds.
#9. 8.5% CAGR (Coherent Market Insights)
Coherent Market Insights projects the ELN market will grow at an 8.5% CAGR, crossing $922M by 2032 from $521M in 2025 — placing ELN among the faster-growing subsegments within the broader laboratory informatics software sector.
#10. $392M → $841.7M (Allied Market Research)
Allied Market Research valued the ELN market at $392M in 2023, forecasting growth to $841.7M by 2033 at a 7.9% CAGR — consistent with the broader industry trend of science-driven digital adoption across research-intensive organisations globally.
#11. $255.19M (US Market, 2024)
The US ELN market alone was valued at $255.19M in 2024, projected to nearly double to $447.82M by 2034 at a 5.78% CAGR — reflecting America’s position as the world’s most mature and well-funded ELN adoption market.
#12. $133.3M (US Cloud ELN Services, 2025)
The US cloud ELN service market was valued at $133.3M in 2025, expected to surge to $412.9M by 2035 at a 12% CAGR — a threefold expansion confirming cloud as the dominant delivery mechanism for ELN in North America.
#13. $613.5M → $1.276B (Market.US CAGR 7.6%)
A second projection from Market.US specifically identifies the 7.6% CAGR as driven by increasing R&D investment, the need for collaborative research tools, and growing government initiatives supporting digital science infrastructure globally.
#14. $709.95M (Reanin, 2024)
Reanin pegs the global ELN software market at $709.95M in 2024, with projections reaching $972.63M by 2031 at a conservative 4.6% CAGR — offering a lower-bound estimate that still represents nearly $263M in incremental market growth.
#15. $566M (SkyQuestTT, 2023) → $871M by 2032
SkyQuestTT valued the ELN market at $566M in 2023, forecasting $871M by 2032 at a 4.9% CAGR, with Thermo Fisher Scientific, Benchling, and LabVantage Software identified as leading vendors shaping competitive dynamics.
#16. $0.6B → $1.1B (Future Market Insights)
Future Market Insights sizes the ELN market at $0.6B in 2025, forecasting $1.1B by 2035 at a 6.5% CAGR — with LIMS integration and AI-powered workflow automation driving the majority of enterprise deal expansion through 2030.
#17. 40 Exabytes of Lab Data Annually
Life sciences laboratories produce approximately 40 exabytes of data annually as of 2025 — a staggering volume that makes structured, searchable, and auditable ELN repositories an operational necessity for research-intensive organisations worldwide.
#18. 120+ Global ELN Vendors
Over 120 ELN vendors operate globally in 2025, yet the top five firms collectively control approximately 55% of the market — a moderately concentrated competitive landscape that analysts expect to consolidate further through strategic M&A activity.
☁️ SECTION 2: Adoption Rates & Deployment Trends (Stats #19–38)
#19. 67.92% Cloud Deployment Share (2024)
Cloud-based platforms held 67.92% of the ELN market in 2024 — a striking majority for a sector once wary of off-premise computing, signalling that security and compliance concerns have been largely overcome by major cloud ELN providers.
#20. 64% of Research Facilities Have Adopted ELN
Approximately 64% of research facilities globally have adopted ELN platforms to improve productivity and experimental documentation quality — leaving a significant 36% greenfield opportunity for vendors offering cost-effective onboarding solutions.
#21. 58% of ELN Deployments Include AI/ML Features
58% of current ELN deployments incorporate AI and machine learning features in 2025, transforming notebooks from passive record systems into active, intelligent research assistants capable of flagging anomalies and suggesting next steps.
#22. 42% of R&D Teams Use Hybrid Cloud + On-Premises Models
42% of R&D teams now adopt hybrid cloud plus on-premises ELN configurations — a pragmatic approach that balances the scalability and remote access benefits of cloud with the data sovereignty and regulatory requirements of on-premises deployment.
#23. 77% of Labs Say COVID Accelerated Digital Transformation
77% of laboratory leaders reported that the COVID-19 pandemic accelerated their digital transformation plans — permanently reshaping lab informatics priorities toward cloud-accessible, remote-friendly ELN tools that support distributed research teams.
#24. 50% of New ELN Contracts Include AI Experiment Planning
50% of new ELN contracts signed in 2024 include an AI-driven experiment planning module — signalling a decisive industry pivot toward predictive lab workflows that reduce costly trial-and-error experimentation and accelerate research timelines.
#25. 68% of New ELN Purchases Include Collaboration Modules
In 2025, approximately 68% of new ELN purchases include collaboration and workflow modules, reflecting researchers’ demand for real-time shared notebooks far beyond simple digital note-taking or data recording functionality.
#26. Software Components Represent Over 70% of ELN Revenue
Software components account for more than 70% of ELN market revenue in 2025, with professional services — including implementation, training, and ongoing support — representing the remainder but growing at a faster rate as deployment complexity increases.
#27. 9.1% CAGR for the ELN Software Segment
The software component of the ELN market is expanding at a 9.1% CAGR — outpacing the overall market average — driven by feature-rich cloud SaaS offerings, AI integrations, and accelerating upsell cycles among existing enterprise clients.
#28. 55.45% Market Share for Cross-Disciplinary ELNs
Cross-disciplinary ELNs — platforms supporting chemistry, biology, and analytical functions — held a 55.45% market share in 2025, reflecting labs’ preference for unified platforms that eliminate the cost and inefficiency of duplicate departmental systems.
#29. Specific ELNs Growing at 8.0% CAGR
Specific, purpose-built ELNs are the fastest-growing product segment at an 8.0% CAGR, as pharmaceutical, biotech, and clinical research teams increasingly demand specialised tools with domain-specific templates, compliance features, and instrument integrations.
#30. 75.2% Cross-Disciplinary ELN Share in 2023
Cross-disciplinary ELNs commanded a 75.2% share in 2023 — a dominant position that is gradually being eroded as specific ELNs gain ground at an 8% CAGR, driven by intensifying specialisation across research disciplines and regulatory environments.
#31. Fewer Than 20% of India’s R&D Labs Use Advanced ELN
Despite India hosting over 3,000 biotechnology and pharmaceutical R&D laboratories, fewer than 20% use advanced ELN solutions — representing a massive untapped opportunity for vendors offering localised, lower-cost, and regulatory-compliant deployment models.
#32. Only ~22% of China’s Life Sciences Institutions Use ELN
China’s life sciences research institutions exceeded 4,500 in 2024, yet ELN uptake remained at approximately 22% — an indicator of significant untapped digitalisation potential in the world’s second-largest R&D market by spending volume.
#33. Benchling Has Attracted Over 200,000 Bench Scientists
Benchling’s freemium model has attracted over 200,000 bench scientists globally — providing invaluable user-experience telemetry that guides its enterprise product roadmap and accelerates feature adoption across large pharmaceutical clients.
#34. LIMS Leads ELN Solution Market with 36.4% Share
Laboratory Information Management Systems (LIMS) lead the ELN solution market with a 36.4% share in 2025, reflecting the accelerating convergence of ELN and LIMS functions into integrated lab informatics platforms that serve the entire research data lifecycle.
#35. 34% of New 2024 ELN Contracts Include Collaboration Tools
34% of new ELN contracts in 2024 specifically include collaboration tools — reflecting a fundamental shift from individual record-keeping toward team-based, real-time scientific knowledge management that mirrors broader enterprise digital workplace trends.
#36. Academic Institutions Represent ~12% of ELN Market
Academic research institutions represent approximately 12% of ELN software market revenue — a segment that prioritises open access, reproducibility, and open-source options, suggesting strong growth potential as research funding pressures ease globally.
#37. ~60% of ELN Installations Use Proprietary Licensing
Proprietary licensing accounts for approximately 60% of ELN installations globally, compared with 40% open-source — though open-source options like eLabFTW are steadily gaining traction in resource-constrained academic and government research settings.
#38. 65% Cloud Software Share of US Cloud ELN Market
Cloud ELN software held a 65% share of total US cloud ELN demand in 2025, driven by real-time data capture capabilities, efficient cross-team record-keeping, and the ease of regulatory audit trail management in cloud-native deployments.
🌍 SECTION 3: Regional Market Breakdown (Stats #39–52)
#39. North America Held 37.65% of Global ELN Market (2025)
North America commanded 37.65% of the global ELN market in 2025, supported by a well-established pharmaceutical research ecosystem, early adoption of digital laboratory tools, and stringent FDA and GxP regulatory enforcement requiring documented, auditable records.
#40. Asia-Pacific CAGR of 8.71% (2026–2031)
Asia-Pacific is projected to record the highest regional ELN CAGR of 8.71% through 2031, fuelled by China and India’s outsourcing-driven R&D expansion and government-backed laboratory digitalisation programmes in South Korea, Japan, and Singapore.
#41. Europe Cloud ELN Market: $225.8M in 2024
Europe’s laboratory cloud ELN market stood at $225.8M in 2024, backed by strong government initiatives promoting healthcare digitalisation, expanding biotech clusters in Germany and the UK, and stringent GDPR-aligned data management requirements.
#42. Asia-Pacific Cloud ELN CAGR of 15.1% (Fastest Region)
Asia-Pacific’s cloud ELN market is growing at a 15.1% CAGR through 2033 — the fastest of any region globally — as China, India, and Southeast Asia collectively ramp up pharmaceutical manufacturing capabilities and R&D outsourcing activity.
#43. Europe Cloud ELN CAGR of 12.2%
The European cloud ELN market is growing at a 12.2% CAGR through 2033, propelled by ongoing investments in cross-border research infrastructure, intensifying industry-academia collaboration, and growing demand for FAIR data-compliant laboratory platforms.
#44. Asia-Pacific Cloud ELN Market: $164.7M in 2024
Asia-Pacific’s cloud ELN market was valued at $164.7M in 2024, with growth driven by increasing pharmaceutical CRO activity across India and China, expanding university research budgets, and government-backed precision medicine initiatives across the region.
#45. US ELN Market Projected to Reach $447.82M by 2034
The US ELN market is projected to reach $447.82M by 2034 — nearly doubling its 2024 value of $255.19M — as pharmaceutical innovation cycles, genomics-led research, and precision medicine programmes continue to intensify R&D data management demands.
#46. US Southern Region Leads Cloud ELN Growth at 12.3% CAGR
Within the US, the Southern region leads cloud ELN growth at a 12.3% CAGR, as pharmaceutical and biotech industries in North Carolina’s Research Triangle and Texas’s life sciences corridor embrace cloud-first digital lab solutions.
#47. US Cloud ELN Market to Triple: $133.3M → $412.9M by 2035
The US cloud ELN market is set to grow approximately threefold from $133.3M in 2025 to $412.9M by 2035 — reflecting the large-scale migration of laboratory operations from legacy on-premises infrastructure to scalable cloud environments.
#48. Fewer Than 20% of India’s 3,000+ R&D Labs Use Advanced ELN
India’s combination of a rapidly growing pharmaceutical sector and extremely low ELN adoption rates below 20% creates one of the most compelling vendor expansion opportunities in the global market, particularly for SaaS-based, compliance-ready solutions.
#49. Only ~22% ELN Uptake Among China’s 4,500+ Life Sciences Institutions
China’s life sciences research ecosystem — spanning over 4,500 institutions — remains largely un-digitised at the lab notebook level, with ELN adoption at approximately 22%, offering a vast opportunity for vendors with Mandarin-language, locally compliant platforms.
#50. Asia-Pacific Held 30% of Global ELN Revenue in 2023
Asia-Pacific held a 30% share of global ELN revenue in 2023 — second only to North America — driven by India and China’s pharmaceutical CRO boom, government-funded digital science initiatives, and expanding clinical research activity across Southeast Asia.
#51. North America Leads with Over 40% Market Share
North America leads the global ELN software market with over 40% share, driven by robust regulatory enforcement under FDA 21 CFR Part 11 and the presence of more than 80% of global pharmaceutical R&D headquarters within the region.
#52. Singapore Becomes a Regional ELN R&D Hub (Aug 2024)
In August 2024, Skills Corporation opened a new R&D Centre in Singapore specifically to support ELN adoption across Asia-Pacific — developing multilingual compliance features tailored to diverse regional regulatory frameworks and local language requirements.
🔬 SECTION 4: End-User Segments & Industry Applications (Stats #53–68)
#53. Pharmaceutical & Biotech = 46.12% of ELN Market (2025)
Pharmaceutical and biotechnology companies accounted for 46.12% of the global ELN market in 2025 — the dominant end-user segment, driven by drug discovery complexity, biologics pipeline growth, and strict regulatory documentation requirements across all research phases.
#54. Pharma/Biotech Contributed ~48% of Revenue in 2024
The pharmaceutical and biotechnology segment contributed nearly 48% of market revenue in 2024, with rising R&D spending on gene therapy, cell therapy, and biologics development all creating intensive demand for structured, audit-ready experiment documentation systems.
#55. CROs Are the Fastest-Growing ELN Segment at 8.25% CAGR
Contract Research Organisations are the fastest-growing ELN end-user segment with an 8.25% CAGR through 2031, reflecting the explosive global outsourcing of pharmaceutical R&D functions and the corresponding need for multi-client, compliant digital documentation platforms.
#56. Academic Research Represents ~12% of ELN Market Revenue
Academic research institutions represent approximately 12% of ELN software market revenue — a segment that strongly values open-source solutions, reproducibility, and data sharing capabilities aligned with open science mandates from major research funding bodies.
#57. Food & Beverage Industry Expected to Post Highest End-User CAGR
Within end-user segments, food and beverage companies are expected to record the highest CAGR as food safety traceability regulations and quality control digitalisation requirements drive ELN adoption well beyond traditional life sciences laboratory environments.
#58. The FDA Issued 529 Warning Letters in 2024
The FDA issued 529 warning letters in 2024, with approximately 8% targeting data integrity violations — directly motivating pharmaceutical laboratories to adopt validated ELN platforms with comprehensive audit trails and electronic signature capabilities.
#59. FDA OAI Remediation Can Exceed $2 Million
Remediation of an FDA Official Action Indicated finding can exceed $2 million in consulting fees, re-inspections, and lost production time — making proactive ELN investment a highly compelling risk-reduction strategy for pharmaceutical and biotech operations.
#60. SciNote Serves Over 90,000 Researchers in 100+ Countries
SciNote ELN serves over 90,000 researchers across more than 100 countries, including scientists at the FDA and USDA — demonstrating the global reach that even mid-market ELN providers can achieve with the right compliance credentials and usability focus.
#61. Drug Discovery Is the Leading ELN Application by Spend
Drug discovery is the leading application for ELN software by spending, followed by clinical research, quality control, and data management — reflecting the pharmaceutical industry’s outsized investment in digital R&D infrastructure relative to other sectors.
#62. Molecular Biology and Genetics Are the Most Intensive ELN Users
In life sciences, ELNs are most heavily utilised in molecular biology, genetics, biochemistry, pharmacology, and microbiology — fields that generate high volumes of structured experimental data demanding systematic digital capture, storage, and retrieval.
#63. Laboratory Informatics Solutions Account for 53.4% of ELN Market
Laboratory informatics solutions are expected to account for 53.4% of the ELN market share by solution type in 2025 — a segment that integrates ELN, LIMS, and quality management functions into unified research data ecosystems for enterprise clients.
#64. Large Organisations Dominate ELN Adoption
Large organisations account for the dominant share of ELN adoption by organisational size, though small and medium-sized enterprises are increasingly targeted through SaaS and freemium pricing models by vendors including Benchling and SciNote.
#65. Service Segment Held the Largest ELN Market Share in 2024
The service component — spanning implementation, validation, training, and support — held the largest ELN market share in 2024, driven by the complexity of deploying validated systems in pharma GxP environments that require extensive change management.
#66. US Pharmaceutical Industry Valued at $1.6 Trillion (2023)
The US pharmaceutical industry was valued at $1.6 trillion in 2023 — a massive ecosystem whose R&D and manufacturing digitalisation requirements create an enormous and enduring long-term addressable market for ELN vendors and lab informatics providers.
#67. Life Sciences Held Largest End-User Share and Highest Growth in 2024
Life sciences held both the largest end-user share and registered the highest forecast growth rate in 2024 — making it the non-negotiable anchor segment for any ELN vendor’s go-to-market strategy and product investment prioritisation decisions.
#68. “Others” Segment (Forensics, Materials, Industrial) = 8% of Revenue
The “others” segment — encompassing forensics laboratories, industrial testing facilities, and materials research — accounts for approximately 8% of ELN revenue, representing an emerging frontier as ELN platforms expand beyond traditional life sciences boundaries.
⚡ SECTION 5: ROI, Productivity & Operational Benefits (Stats #69–84)
#69. Researchers Save an Average of 9 Hours Per Week
Researchers save an average of 9 hours per week after implementing an ELN — a remarkable productivity gain equivalent to reclaiming 22.5% more productive research time each week without any additional headcount investment.
#70. Peak Savings Reach Up to 17 Hours Per Week
High-efficiency ELN users report time savings reaching up to 17 hours per week — equivalent to more than two full working days reclaimed from administrative documentation tasks and redirected toward active scientific discovery and experimentation.
#71. ELN Users Spend 33% Less Time on Reporting
ELN users spend 33% less time on reporting tasks, largely due to auto-generated project summaries, structured data templates, and one-click report exports that eliminate the manual copy-paste workflows historically required in paper-based laboratory environments.
#72. Scheduling and Planning Time Reduced by 16%
Researchers save 16% of time previously spent on scheduling and planning after ELN adoption, enabled by integrated workflow calendars, reusable protocol templates, and shared experiment timelines that streamline project coordination across research teams.
#73. Email Time Reduced by 6% After ELN Implementation
ELN adoption reduces time spent managing email by 6%, as centralised notebook sharing and in-platform notifications replace scattered email threads previously used for experiment updates, data sharing, and collaborative scientific discussions.
#74. Measurable ROI Achievable Within 3 to 4 Months
Electronic lab notebooks can deliver measurable return on investment within just 3 to 4 months of implementation — making the business case for ELN adoption unusually compelling relative to other enterprise software categories that often require 12–18 months to demonstrate value.
#75. Users Report Up to 5 Additional Hours Per Week for Research
SciNote users report gaining up to 5 additional hours per week that can be reinvested directly into research activities or used to improve work-life balance — a quantifiable personal productivity benefit that drives grassroots adoption within research organisations.
#76. 6 Out of 7 ELN Users Report Substantial Time Savings
Six out of seven ELN users reported substantial time savings after transitioning from paper-based laboratory notebooks — an adoption satisfaction rate that rivals best-in-class enterprise productivity software across all technology categories.
#77. One Researcher Reduced Reporting from 3 Hours/Week to 3 Hours/Month
A PhD researcher at the University of Stavanger reduced weekly reporting time from 3 hours per week to just 3 hours per month after adopting an ELN — a 75% reduction that validates ELN’s transformative impact on research documentation overhead.
#78. ELNs Dramatically Improve Regulatory Audit Readiness
ELNs reduce audit preparation time significantly by providing instant access to timestamped, immutable electronic records — directly addressing the ALCOA+ (Attributable, Legible, Contemporaneous, Original, Accurate) compliant data management requirements in pharma and biotech environments.
#79. Inventory Control and Cost Reduction Through LIMS Integration
ELNs integrated with LIMS automate inventory control, reagent ordering, and equipment calibration tracking — reducing material waste, preventing costly reagent expiry losses, and lowering supply chain costs across research laboratories of all sizes.
#80. Physical Paper Storage Costs Eliminated
ELN adoption eliminates the need for physical paper storage — with large pharmaceutical laboratories historically maintaining thousands of paper notebooks, the space savings, administrative overhead reduction, and risk elimination alone can justify implementation costs.
#81. Real-Time Multi-User Collaboration Becomes Possible
ELNs enable multiple researchers to work simultaneously on the same experimental notebook — a collaborative capability fundamentally impossible with paper systems, accelerating multi-disciplinary research project timelines and reducing harmful knowledge silos across teams.
#82. Data Loss Prevention and Business Continuity Assured
ELNs provide automated backup and rapid restoration capabilities that safeguard against catastrophic data loss — a critical advantage given that lost or damaged paper notebooks can represent months of irreplaceable experimental work and core intellectual property.
#83. ELN Adoption Supports Corporate Sustainability and ESG Goals
ELN adoption contributes to laboratory sustainability by reducing paper consumption, lowering physical storage energy requirements, and contributing to green laboratory certification programmes aligned with growing corporate ESG mandates and sustainability reporting obligations.
#84. Tamper-Proof Records Protect Intellectual Property and Patent Rights
ELNs create tamper-proof electronic records with cryptographic date and time stamps and legally recognised digital signatures — critical for patent applications, intellectual property litigation, and establishing proof of invention date in competitive pharmaceutical R&D environments.
🏆 SECTION 6: Competitive Landscape, M&A & Technology Trends (Stats #85–100)
#85. Siemens Acquired Dotmatics for $5.1 Billion (April 2025)
Siemens’ $5.1 billion acquisition of Dotmatics in April 2025 represents the largest ELN-adjacent M&A deal in recent memory, expanding Siemens’ Digital Twin portfolio into an $11 billion life sciences total addressable market with $100 million in projected annual synergies.
#86. Top 5 Firms Control ~55% of the Global ELN Market
The top five ELN vendors — Revvity, Dassault Systèmes, Benchling, Thermo Fisher Scientific, and Waters Corporation — collectively hold approximately 55% of the global ELN market, leaving 45% fragmented among 115+ niche and regional competitors.
#87. Siemens Projects an $11 Billion Life Sciences TAM
Following the Dotmatics acquisition, Siemens projects an $11 billion total addressable market in life sciences — a projection that signals ELN software sits squarely at the intersection of pharmaceutical companies’ most strategic digital investment priorities for the decade ahead.
#88. Thermo Fisher Integrated AI/ML into ELN Suite (October 2024)
In October 2024, Thermo Fisher Scientific expanded its ELN suite with AI and machine learning capabilities for real-time data analysis — a strategic move targeting large pharmaceutical clients who need intelligent data insights embedded directly in their experimental workflows.
#89. Certara Acquired ChemAxon for Cheminformatics Depth (2024)
Certara’s 2024 acquisition of ChemAxon strengthened its cheminformatics capabilities within model-informed drug development — reflecting the broader industry consolidation trend toward integrated R&D data platforms that encompass ELN, modelling, and regulatory submission functions.
#90. Benchling Attracted 200,000+ Bench Scientists via Freemium
Benchling’s freemium model has attracted over 200,000 bench scientists, providing invaluable user-experience telemetry that guides its enterprise product roadmap and accelerates commercial feature adoption at large pharmaceutical and biotech organisations worldwide.
#91. Scilligence Launched ELN4edu for Academic Labs (July 2024)
Scilligence’s ELN4edu platform, launched in July 2024, specifically targets academic institutions — providing tailored tools for educational collaboration, structured experiment management, and data sharing among student and faculty research teams.
#92. LabArchives Achieved FedRAMP and GovRAMP Authorisation
LabArchives achieved FedRAMP authorisation and GovRAMP membership — enabling US federal government agencies, national laboratories, and defence research facilities to adopt its ELN platform with confidence that security standards meet NIST 800-53 requirements.
#93. SciNote Holds ISO 27001 Certification
SciNote holds ISO 27001 information security certification and serves researchers at the FDA and USDA — demonstrating that mid-market ELN providers can achieve enterprise-grade security credentials that satisfy the most demanding regulated research environments.
#94. Körber AG and LabWare Announced LIMS Integration (November 2023)
Körber AG and LabWare announced the PAS-X LIMS Integration program in November 2023, connecting pharmaceutical manufacturing execution systems with laboratory information management — a convergence trend pointing toward end-to-end digital lab ecosystems spanning production and R&D.
#95. Global Cloud ELN Market Growing at 12.8% CAGR Through 2033
The global laboratory cloud ELN market is growing at a 12.8% CAGR through 2033 — significantly faster than the overall ELN market — confirming that cloud-first deployment is the defining strategic shift reshaping the competitive landscape this decade.
#96. Global Cloud ELN Market to Reach $2.45B by 2033
The global laboratory cloud ELN market is forecast to reach $2.45 billion by 2033 from $823.7 million in 2024 — a near-tripling in under a decade that underscores cloud infrastructure as the primary engine of ELN market expansion globally.
#97. eLabFTW Has Been Actively Developed for 12+ Years
Open-source ELN eLabFTW has maintained active development for over 12 years with 41+ contributors — providing regulated laboratories a transparent, auditable, and vendor-independent alternative to proprietary ELN systems at near-zero licensing cost.
#98. ELN Software Specifically Growing at 9.5% CAGR (2025–2033)
The ELN software market specifically is projected to grow at a 9.5% CAGR from 2025 to 2033 — among the fastest growth rates in the broader laboratory informatics sector — driven by AI-powered automation and cloud-native architecture adoption.
#99. LIMS-ELN Convergence Is the Defining Platform Trend
The integration of ELN functionality into LIMS platforms is the defining market trend of 2025–2026, future-proofing laboratory data management by creating unified ecosystems where sample tracking, experiment documentation, and quality control data reside in one searchable, auditable system.
#100. LabArchives Launched a Mobile-First ELN App (January 2025)
LabArchives’ January 2025 launch of a mobile-first ELN application with offline data entry, image capture, and speech-to-text lab notes signals a new era of bench-side and field-accessible digital documentation — extending ELN utility well beyond traditional desktop laboratory workstations.
Conclusion
The Top 100 Electronic Lab Notebook (ELN) Software Statistics, Data & Trends in 2026 point to an industry moving decisively from digital record-keeping toward intelligent, connected laboratory infrastructure. ELNs are increasingly becoming central platforms for managing experiments, research data, collaboration, regulatory documentation, intellectual property, and scientific workflows across pharmaceutical, biotechnology, academic, clinical, and industrial laboratories.
Market forecasts reinforce this trajectory. The compiled data includes projections of the ELN market reaching $1.03 billion by 2030 and approximately $1.4 billion by 2034, while the global laboratory cloud ELN market is forecast to expand at a 12.8% CAGR through 2033. Cloud deployment already represented 67.92% of the ELN market in 2024, demonstrating how quickly laboratories are moving toward scalable and remotely accessible research environments.
Artificial intelligence is another major force shaping the Electronic Lab Notebook software market in 2026. The statistics indicate that 58% of ELN deployments incorporate AI or machine-learning features, while 50% of new ELN contracts signed in 2024 included AI-driven experiment-planning modules. As these capabilities mature, ELNs have the potential to evolve from repositories of past experiments into active research systems that help scientists analyse information, identify anomalies, automate workflows, and plan future experiments.
The productivity argument is equally significant. Researchers reportedly save an average of nine hours per week following ELN implementation, with high-efficiency users achieving savings of up to 17 hours per week. ELN users also spend 33% less time on reporting, while measurable ROI can potentially be achieved within three to four months. These figures illustrate why organisations increasingly evaluate ELN adoption not simply as an IT expense but as an investment in research productivity and operational efficiency.
Regional and industry trends suggest considerable room for further expansion. North America remains the leading ELN market, but Asia-Pacific is projected to record an 8.71% CAGR through 2031, while its cloud ELN segment is forecast to grow at 15.1% annually through 2033. Pharmaceutical and biotechnology companies remain the largest end-user group, representing 46.12% of the global ELN market in 2025, while contract research organisations are among the fastest-growing customer segments.
Competition is also likely to intensify as ELN, LIMS, AI, cloud infrastructure, mobile research tools, and broader laboratory informatics platforms increasingly converge. Major transactions such as Siemens’ $5.1 billion acquisition of Dotmatics in April 2025 demonstrate the strategic importance that large technology companies are placing on digital life sciences infrastructure. At the same time, proprietary platforms, specialised ELNs, and open-source alternatives continue to give laboratories a widening range of deployment and pricing options.
Ultimately, the Electronic Lab Notebook statistics for 2026 show that the industry’s next phase will be about much more than replacing paper notebooks. The direction of travel is toward integrated digital laboratories where experiments, samples, instruments, researchers, compliance records, and scientific knowledge can operate within connected data ecosystems. As cloud adoption accelerates and AI becomes embedded deeper into research workflows, ELN software is positioned to become an increasingly important foundation for faster, more collaborative, auditable, and data-driven scientific discovery.
If you find this article useful, why not share it with your hiring manager and C-level suite friends and also leave a nice comment below?
We, at the 9cv9 Research Team, strive to bring the latest and most meaningful data, guides, and statistics to your doorstep.
To get access to top-quality guides, click over to 9cv9 Blog.
To hire top talents using our modern AI-powered recruitment agency, find out more at 9cv9 Modern AI-Powered Recruitment Agency.
People Also Ask
What is Electronic Lab Notebook (ELN) software?
Electronic Lab Notebook (ELN) software is a digital platform for recording, organizing, searching, sharing, and protecting laboratory experiments and research data. It replaces traditional paper notebooks while supporting collaboration, audit trails, compliance, and data management.
How big is the Electronic Lab Notebook software market in 2026?
Market estimates vary by methodology. Mordor Intelligence estimates the global ELN market at approximately $512.45 million in 2026, up from $480.44 million in 2025.
How fast is the ELN software market growing?
Growth forecasts vary by market definition. Mordor Intelligence projects a 6.66% CAGR from 2026 to 2031, while other forecasts in the dataset range from roughly 4.6% to more than 10%.
How large will the Electronic Lab Notebook market be by 2030?
MarketsandMarkets projects the Electronic Lab Notebook market to reach approximately $1.03 billion by 2030, representing a 7.3% CAGR.
What is driving ELN software market growth in 2026?
ELN growth is being driven by laboratory digitalization, cloud adoption, AI integration, regulatory compliance, research collaboration, expanding R&D investment, laboratory automation, and demand for structured scientific data.
What percentage of research facilities use Electronic Lab Notebooks?
Approximately 64% of research facilities globally have adopted ELN platforms, according to the compiled statistics, leaving considerable room for further adoption among laboratories still relying on traditional systems.
What percentage of the ELN market is cloud-based?
Cloud-based platforms accounted for approximately 67.92% of the ELN market in 2024, demonstrating the growing preference for scalable, remotely accessible laboratory software over traditional on-premises deployments.
How fast is the cloud ELN market growing?
The global laboratory cloud ELN market is projected to grow at a 12.8% CAGR through 2033, considerably faster than several forecasts for the overall Electronic Lab Notebook market.
How large could the cloud ELN market become?
The global laboratory cloud ELN market is forecast to increase from approximately $823.7 million in 2024 to $2.45 billion by 2033, representing nearly threefold growth.
How is AI being used in Electronic Lab Notebook software?
AI and machine learning are being incorporated into ELNs for experiment planning, real-time data analysis, anomaly detection, workflow automation, and research assistance. The dataset states that 58% of current ELN deployments include AI or ML features.
What percentage of new ELN contracts include AI experiment planning?
Approximately 50% of new ELN contracts signed in 2024 included an AI-driven experiment planning module, indicating growing demand for ELNs that actively support scientific workflows rather than simply store records.
What are the biggest Electronic Lab Notebook trends in 2026?
Major ELN trends include cloud-first deployment, AI-powered research workflows, LIMS-ELN convergence, mobile data capture, real-time collaboration, stronger compliance capabilities, laboratory automation, and integrated research data ecosystems.
Which region has the largest Electronic Lab Notebook market?
North America is the leading ELN region. One estimate in the dataset gives it 37.65% of the global market in 2025, supported by pharmaceutical R&D, digital laboratory adoption, and stringent regulatory requirements.
Which region has the fastest-growing ELN market?
Asia-Pacific is projected to record the fastest overall regional growth, with a CAGR of 8.71% from 2026 to 2031. Its cloud ELN segment is projected to grow even faster at 15.1% through 2033.
How large is the US Electronic Lab Notebook market?
The US ELN market was valued at approximately $255.19 million in 2024 and is projected to reach $447.82 million by 2034, representing a forecast CAGR of 5.78%.
Which industries use Electronic Lab Notebook software the most?
Pharmaceutical and biotechnology companies are the dominant ELN users, accounting for 46.12% of the global market in 2025. Academic research, CROs, food and beverage, forensics, materials research, and industrial laboratories also use ELNs.
Why do pharmaceutical companies use ELN software?
Pharmaceutical companies use ELNs to document complex experiments, manage research data, support drug discovery, improve collaboration, maintain audit-ready records, and address stringent regulatory and data integrity requirements.
Are Contract Research Organisations increasing their use of ELNs?
Yes. Contract Research Organisations are identified as the fastest-growing ELN end-user segment, with a projected CAGR of 8.25% through 2031 as pharmaceutical companies increasingly outsource research activities.
How much time can researchers save by using an ELN?
Researchers reportedly save an average of nine hours per week after implementing an ELN. High-efficiency users can achieve savings of up to 17 hours per week by reducing documentation and administrative work.
Can Electronic Lab Notebook software reduce reporting time?
Yes. According to the compiled statistics, ELN users spend 33% less time on reporting through features such as structured templates, automated project summaries, searchable records, and simplified report exports.
How quickly can an Electronic Lab Notebook deliver ROI?
The dataset indicates that measurable ELN return on investment can potentially be achieved within three to four months, particularly when productivity gains and reduced documentation workloads are considered.
How does ELN software improve laboratory collaboration?
ELNs enable researchers to share notebooks, access experimental information, coordinate workflows, and collaborate on records in real time. Approximately 68% of new ELN purchases in 2025 reportedly include collaboration and workflow modules.
How does ELN software support regulatory compliance?
ELNs can provide timestamped records, audit trails, electronic signatures, searchable documentation, and controlled research data, helping regulated laboratories improve data integrity and prepare for audits.
What is the difference between ELN and LIMS software?
ELNs primarily focus on experimental documentation and research workflows, while LIMS traditionally emphasizes samples and laboratory processes. A major 2026 trend is convergence, with platforms increasingly combining ELN and LIMS capabilities.
Are ELN and LIMS platforms becoming integrated?
Yes. LIMS-ELN convergence is identified as a defining industry trend for 2025–2026, creating unified environments where sample tracking, experiment documentation, research data, and quality-control information can coexist.
Are cross-disciplinary Electronic Lab Notebooks popular?
Yes. Cross-disciplinary ELNs supporting areas such as chemistry, biology, and analytical research held a reported 55.45% market share in 2025 as laboratories increasingly seek unified platforms.
Are open-source Electronic Lab Notebooks widely used?
The dataset estimates that approximately 40% of ELN installations use open-source software, compared with about 60% using proprietary licensing. Open-source platforms such as eLabFTW are gaining traction in academic and government research.
How competitive is the Electronic Lab Notebook software market?
More than 120 ELN vendors reportedly operate globally, while the top five vendors collectively control approximately 55% of the market. This leaves a substantial portion distributed among specialist, regional, and emerging providers.
Why is Electronic Lab Notebook software important for research data management?
Life sciences laboratories reportedly generate about 40 exabytes of data annually. ELNs help turn expanding experimental datasets into structured, searchable, shareable, backed-up, and auditable research records.
What is the future of Electronic Lab Notebook software beyond 2026?
ELNs are moving toward cloud-based, AI-enabled laboratory ecosystems integrating experiments, samples, workflows, collaboration, compliance, and LIMS functionality. Market forecasts suggest sustained expansion through 2030 and beyond.
Sources
MarketsandMarkets Mordor Intelligence Toward Healthcare Verified Market Research Verified Market Reports Precedence Research Future Market Insights Growth Market Reports Coherent Market Insights Allied Market Research SkyQuestTT Market.US Reanin DataIntelo Industry Research Biz SciNote Scientific Computing World BioaccessLA LabKey DIMA Engineering Technology Networks Codephusion Qualityze PLOS Computational Biology Spherical Insights Data Insights Market Grand View Research LabArchives Siemens AG